Successful caspofungin treatment of invasive refractory candidiasis: In the extremely low birthweight neonate;Utilização com sucesso de caspofungina na candidíase invasiva refractária: No recém-nascido de extremo baixo peso

Acta Medica Portuguesa

Volumn 23, Issue 4, 2010, Pages 719-722

  Lopes, Andreia ^a   Rocha, Gustavo ^a   Vilan, Ana ^a   Guedes, Maria Beatriz ^a   Guimarães, Hercília ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CLOTRIMAZOLE; NYSTATIN; ANTIFUNGAL AGENT; ECHINOCANDIN;

ARTICLE; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS; CASE REPORT; FEMALE; HUMAN; LOW BIRTH WEIGHT; MUCOCUTANEOUS CANDIDIASIS; NEWBORN; SEPTICEMIA; EXTREMELY LOW BIRTH WEIGHT; PREMATURITY; REMISSION;

ANTIFUNGAL AGENTS; CANDIDIASIS; ECHINOCANDINS; FEMALE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; REMISSION INDUCTION;

EID: 78349247931     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. LAMAGNI TL, EVANS BC, SHIGMATSU M, JOHNSON EM: Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001;126:397-414
2. TORTORANO AM, PEMAN J, BERNHARDT H et al: ECMM Working Group on Candidaemia. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004;23:317-322
3. BENJAMIN DK Jr, POOLE C, STEINBACH WJ, ROWEN JL, WALSH TJ: Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112:634-640
4. TRICK WE, FRIDKIN SK, EDWARDS JR, HAJJEH RA, GAYNES RP: National Nosocomial Infections Surveillance System Hospitals. Secular trends of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 1999;29:253-8
5. BALEY JE, KLIEGMAN RM, FANAROFF AA: Disseminated fungal infections in very low birth weight infants: therapeutic toxicity. Pediatrics 1984;73:153-7
6. ZAOUTIS TE, FORAKER E, McGOWAN KL et al: Anfifungal susceptibility of Candida spp. isolated from pediatric patients: A survey of 4 children's hospitals. Diag Microbiol Infect Dis 2005;52:295-8
7. ALMIRANTE B, RODRÍGUEZ D: Antifungal Agents in Neonates. Issues and Recommendations. Pediatr Drugs 2007;9:311-321
8. FRATTARELLI DAC, REED MD, GIACOIA GP, ARANDA JV: Antifungals in Systemic Neonatal Candidiasis. Pediatr Drugs 2004;64:949-968
9. WALSH TJ, ADAMSON PC, SEIBEL NL et al: Pharmacokinetics, Safety, and Tolelability of Caspofungin in Children and Adolescents. Antimicrob Agents Chemother 2005;49:4536-45
10. HESSLING M, WEINDLING M, NEAL T: First reported use of caspofungin in an extremely low-birth-weight neonate. J Maternal-Fetal Neonatal Med 2003;14:212
11. ÓDIO CM, ARAYA R, PINTO LE et al: Caspofungin Therapy of Neonates With Invasive Candidiasis. Ped Inf Dis J 2004;23:1093-6
12. STEINBACH WJ, BENJAMIN DK: New antifungal agents under development in children and neonates. Curr Opin Infect Dis 2005;18:484-9